BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 23831411)

  • 1. Cognitive, motor and tyrosine hydroxylase temporal impairment in a model of parkinsonism induced by reserpine.
    Santos JR; Cunha JA; Dierschnabel AL; Campêlo CL; Leão AH; Silva AF; Engelberth RC; Izídio GS; Cavalcante JS; Abílio VC; Ribeiro AM; Silva RH
    Behav Brain Res; 2013 Sep; 253():68-77. PubMed ID: 23831411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated treatment with a low dose of reserpine as a progressive model of Parkinson's disease.
    Fernandes VS; Santos JR; Leão AH; Medeiros AM; Melo TG; Izídio GS; Cabral A; Ribeiro RA; Abílio VC; Ribeiro AM; Silva RH
    Behav Brain Res; 2012 May; 231(1):154-63. PubMed ID: 22446059
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposure to an enriched environment facilitates motor recovery and prevents short-term memory impairment and reduction of striatal BDNF in a progressive pharmacological model of parkinsonism in mice.
    Campêlo CLC; Santos JR; Silva AF; Dierschnabel AL; Pontes A; Cavalcante JS; Ribeiro AM; Silva RH
    Behav Brain Res; 2017 Jun; 328():138-148. PubMed ID: 28432010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in the mesocorticolimbic pathway after low dose reserpine-treatment in Wistar and Spontaneously Hypertensive Rats (SHR): Implications for cognitive deficits in a progressive animal model for Parkinson's disease.
    Leão AHFF; Meurer YSR; Freitas TA; Medeiros AM; Abílio VC; Izídio GS; Conceição IM; Ribeiro AM; Silva RH
    Behav Brain Res; 2021 Jul; 410():113349. PubMed ID: 33971246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Social enrichment attenuates nigrostriatal lesioning and reverses motor impairment in a progressive 1-methyl-2-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease.
    Goldberg NR; Fields V; Pflibsen L; Salvatore MF; Meshul CK
    Neurobiol Dis; 2012 Mar; 45(3):1051-67. PubMed ID: 22198503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation by Nardostachys jatamansi of 6-hydroxydopamine-induced parkinsonism in rats: behavioral, neurochemical, and immunohistochemical studies.
    Ahmad M; Yousuf S; Khan MB; Hoda MN; Ahmad AS; Ansari MA; Ishrat T; Agrawal AK; Islam F
    Pharmacol Biochem Behav; 2006 Jan; 83(1):150-60. PubMed ID: 16500697
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Female Rats Are Resistant to Cognitive, Motor and Dopaminergic Deficits in the Reserpine-Induced Progressive Model of Parkinson's Disease.
    Lima AC; Meurer YSR; Bioni VS; Cunha DMG; Gonçalves N; Lopes-Silva LB; Becegato M; Soares MBL; Marinho GF; Santos JR; Silva RH
    Front Aging Neurosci; 2021; 13():757714. PubMed ID: 34759815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aging accentuates decrease in tyrosine hydroxylase immunoreactivity associated with the increase in the motor impairment in a model of reserpine-induced parkinsonism.
    Melo JEC; Santos TFO; Santos RS; Franco HS; Monteiro MCN; Bispo JMM; Mendonça MS; Ribeiro AM; Silva RH; Gois AM; Marchioro M; Lins LCRF; Santos JR
    J Chem Neuroanat; 2022 Nov; 125():102162. PubMed ID: 36115503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sex differences in the progressive model of parkinsonism induced by reserpine in rats.
    Bispo JMM; Melo JEC; Gois AM; Leal PC; Lins LCRF; Souza MF; Medeiros KAAL; Ribeiro AM; Silva RH; Marchioro M; Santos JR
    Behav Brain Res; 2019 May; 363():23-29. PubMed ID: 30690108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carvacrol prevents impairments in motor and neurochemical parameters in a model of progressive parkinsonism induced by reserpine.
    Lins LCRF; Souza MF; Bispo JMM; Gois AM; Melo TCS; Andrade RAS; Quintans-Junior LJ; Ribeiro AM; Silva RH; Santos JR; Marchioro M
    Brain Res Bull; 2018 May; 139():9-15. PubMed ID: 29378222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral and neurochemical effects induced by reserpine in mice.
    de Freitas CM; Busanello A; Schaffer LF; Peroza LR; Krum BN; Leal CQ; Ceretta AP; da Rocha JB; Fachinetto R
    Psychopharmacology (Berl); 2016 Feb; 233(3):457-67. PubMed ID: 26514557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cognitive and anxiety-like impairments accompanied by serotonergic ultrastructural and immunohistochemical alterations in early stages of parkinsonism.
    Leal PC; Bispo JMM; Lins LCRF; Souza MF; Gois AM; Moore C; Marchioro M; Ribeiro AM; Silva RH; Meshul CK; Santos JR
    Brain Res Bull; 2019 Mar; 146():213-223. PubMed ID: 30641120
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atorvastatin improves cognitive, emotional and motor impairments induced by intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in rats, an experimental model of Parkinson's disease.
    Castro AA; Wiemes BP; Matheus FC; Lapa FR; Viola GG; Santos AR; Tasca CI; Prediger RD
    Brain Res; 2013 Jun; 1513():103-16. PubMed ID: 23548600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physical exercise improves motor and short-term social memory deficits in reserpinized rats.
    Aguiar AS; Araújo AL; da-Cunha TR; Speck AE; Ignácio ZM; De-Mello N; Prediger RD
    Brain Res Bull; 2009 Aug; 79(6):452-7. PubMed ID: 19463920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep deprivation induces late deleterious effects in a pharmacological model of Parkinsonism.
    Lopes-Silva LB; Cunha DMG; Lima AC; Bioni VS; Gonçalves N; Kurita JPF; Wuo-Silva R; Silva RH
    Exp Brain Res; 2024 May; 242(5):1175-1190. PubMed ID: 38499659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term behavioral effects of functional dopaminergic neurons generated from human neural stem cells in the rat 6-OH-DA Parkinson's disease model. Effects of the forced expression of BCL-X(L).
    Ramos-Moreno T; Castillo CG; Martínez-Serrano A
    Behav Brain Res; 2012 Jun; 232(1):225-32. PubMed ID: 22537773
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spontaneously Hypertensive Rats (SHR) Are Resistant to a Reserpine-Induced Progressive Model of Parkinson's Disease: Differences in Motor Behavior, Tyrosine Hydroxylase and α-Synuclein Expression.
    Leão AH; Meurer YS; da Silva AF; Medeiros AM; Campêlo CL; Abílio VC; Engelberth RC; Cavalcante JS; Izídio GS; Ribeiro AM; Silva RH
    Front Aging Neurosci; 2017; 9():78. PubMed ID: 28396635
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nociception alterations precede motor symptoms in a progressive model of parkinsonism induced by reserpine in middle-aged rats.
    Cintra RR; Lins LCRF; Medeiros KAAL; Souza MF; Gois AM; Bispo JMM; Melo MS; Leal PC; Meurer YSR; Ribeiro AM; Silva RH; Marchioro M; Santos JR
    Brain Res Bull; 2021 Jun; 171():1-9. PubMed ID: 33675933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective potential of Aloe arborescens against copper induced neurobehavioral features of Parkinson's disease in rat.
    Abbaoui A; Hiba OE; Gamrani H
    Acta Histochem; 2017 Jun; 119(5):592-601. PubMed ID: 28619286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alterations in TH- and ChAT-immunoreactive neurons in the DMV and gastric dysmotility in an LPS-induced PD rat model.
    Zheng LF; Zhang Y; Chen CL; Song J; Fan RF; Cai QQ; Wang ZY; Zhu JX
    Auton Neurosci; 2013 Oct; 177(2):194-8. PubMed ID: 23701914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.